An official website of the United States government
Government Funding Lapse Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at opm.gov.
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
Trial Status: active
This study evaluates the effect of bladder cancer treatment on quality of life.
Inclusion Criteria
* > or = 18 years of age;
* Have pathologically confirmed, clinically localized, bladder cancer
* Be willing to complete a survey in English before starting definitive treatment (surgery or radiation);
* Able to give consent.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06350734.
I. To compare general and disease-specific quality of life outcomes at 6, 12, 24, and 36 months after treatment for localized bladder cancer using the PROMIS-29 and the Bladder Cancer Index (BCI) respectively.
II. To identify patient level characteristics that may influence quality of life outcomes after treatment for localized bladder cancer.
OUTLINE: This is an observational study.
Patients complete surveys and also have their medical records reviewed on study.